Is Fidelity's Health Care ETF A Good Buy Right Now?

Healthcare investing offers defensive characteristics during market turbulence, yet regulatory uncertainty and political risk can trigger sudden selloffs.

24/7 Wall Street • Jan 10, 2026

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

The Fidelity MSCI Health Care Index ETF (FHLC) was launched on October 21, 2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

Zacks Investment Research • Jan 5, 2026

FHLC: Why Patience Matters More Than Precision

Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech innovation, but requires patience through cycles. FHLC's market-cap weighting enables dynamic exposure, reducing biotech risk in downturns and capturing upside in rallies, outperforming pure biotech or pharma over a decade. Currently, FHLC is highly concentrated in pharma, with Eli Lilly and Company at ~13%, which enhances near-term resilience but increases drawdown risk if heavyweights underperform.

Seeking Alpha • Dec 23, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Midyear Sector Roundup: AI Enthusiasm Drives Returns

Midyear can be an ideal opportunity for investors to re-evaluate their portfolios and consider rebalancing to align with their ideal asset allocation. As the midpoint of 2025 passes, the U.S. stock market has delivered a mixed bag of performance across sectors, driven largely by continued enthusiasm for artificial intelligence (AI) and fluctuating economic conditions.

ETF Trends • Aug 20, 2025

FHLC: An Average Healthcare ETF

FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar expense ratio. FHLC's high concentration in top holdings and lower trading volume raise concerns compared to VHT's broader portfolio and superior liquidity. Healthcare sector tailwinds like innovation, aging demographics, and biotech growth benefit all major ETFs, but VHT stands out on key metrics.

Seeking Alpha • Jul 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

FHLC: Poised To Capture Strong Healthcare Demand And Growth

Fidelity MSCI Health Care Index ETF is a buy due to its strong healthcare holdings, low fees, and solid performance track record. FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds with a 10-year CAGR of 9.32% and an expense ratio of 0.08%. Top holdings like Eli Lilly, UnitedHealth Group, and Johnson & Johnson are poised for future growth, enhancing FHLC's potential for long-term gains.

Seeking Alpha • Mar 4, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Alpha • Feb 25, 2025

Fidelity Crosses $100 Billion ETF Milestone

In mid-November, Fidelity Investments joined the select ‘$100 billion in ETF assets' club. While the firm still has a sizable presence in the mutual fund world, Fidelity's ETFs have been gaining traction in 2024.

ETF Trends • Nov 21, 2024